Hemp & Regulatory Coverage
Where federal law, state law, and real-world enforcement don't align — explained clearly for people who need to know.
Hemp-Derived THC Legality by State
Hover any state to see where hemp, delta-8, and THCA stand right now.
All Hemp Coverage
The DEA has restated its position that cannabinoids produced through chemical conversion — including delta-8 THC and HHC — are synthetically derived and therefore illegal under the Controlled Substances Act, regardless of their hemp source. Hours earlier, the White House signaled the same intent in its sweeping 2026 National Drug Control Strategy, even as Target quietly expanded hemp THC drinks into hundreds of stores.
The president's social media post praising hemp-derived CBD is the most public White House endorsement the hemp industry has ever gotten. What it doesn't do is change anything — yet.
Congress never intended the Farm Bill's 0.3% delta-9 threshold to become a backdoor for intoxicating products. Now that it has, the resulting backlash threatens to erase eight years of legitimate hemp investment.
President Trump posted a public call on Truth Social urging Congress to protect full-spectrum CBD products before a November restriction takes effect. The hemp industry welcomed it — but has heard reassuring words before.
The Hemp Safety Enforcement Act, introduced by a bipartisan group of senators, would give states the ability to maintain their own hemp-derived cannabinoid markets instead of facing a sweeping federal prohibition in November 2026. Here's what the bill actually proposes — and why the gap between federal law and state law is the whole point.
The November 2026 deadline under P.L. 119-37 is real, and industry groups are already pressing Congress for relief. Here's what an extension would actually require — and why the Texas injunction may have complicated the math.
A Texas judge issued a temporary restraining order blocking enforcement of the state's THCA ban. See what the ruling means for hemp retailers and consumers.
CMS launched a pilot on April 1 that lets Medicare-connected organizations give patients up to $500 in hemp-derived CBD products. The FDA hasn't approved any of them. Now there's a federal lawsuit — and Congress may soon pull the rug out from under the whole program.
The Grey Zone
Most hemp legal analysis is written for lawyers. The Grey Zone is written for everyone else — retailers, consumers, brands, and anyone trying to figure out what they can actually do in their state. Where federal law, state law, and real-world enforcement don't match, Morgan Ellis explains what the confusion means in plain English.